Literature DB >> 11665287

Role of macrophages in the pathogenesis of diabetic nephropathy.

K Shikata1, H Makino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11665287     DOI： 10.1159/000060147

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  20 in total

1.  Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.

Authors:  Ahmed A Elmarakby; Jessica Faulkner; Mohammed Al-Shabrawey; Mong-Heng Wang; Krishna Rao Maddipati; John D Imig
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

2.  Intercellular adhesion molecule-1 plays a critical role in glomerulosclerosis after subtotal nephrectomy.

Authors:  Yuichi Kido; Daisuke Ogawa; Kenichi Shikata; Motofumi Sasaki; Ryo Nagase; Shinichi Okada; Hitomi Usui Kataoka; Jun Wada; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2010-12-23       Impact factor: 2.801

Review 3.  The pathologic continuum of diabetic vascular disease.

Authors:  Gabriela Orasanu; Jorge Plutzky
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

4.  Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes.

Authors:  M A Saleh; E I Boesen; J S Pollock; V J Savin; D M Pollock
Journal:  Diabetologia       Date:  2010-12-30       Impact factor: 10.122

5.  Increased IL-12 and decreased IL-33 serum levels are associated with increased Th1 and suppressed Th2 cytokine profile in patients with diabetic nephropathy (CURES-134).

Authors:  Gowrishankar Anand; Rathinam Vasanthakumar; Vishwanathan Mohan; Subash Babu; Vivekanandhan Aravindhan
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 6.  Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.

Authors:  Juan F Navarro-González; Carmen Mora-Fernández; Mercedes Muros de Fuentes; Javier García-Pérez
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

Review 7.  Mouse models of diabetic nephropathy.

Authors:  Frank C Brosius; Charles E Alpers; Erwin P Bottinger; Matthew D Breyer; Thomas M Coffman; Susan B Gurley; Raymond C Harris; Masao Kakoki; Matthias Kretzler; Edward H Leiter; Moshe Levi; Richard A McIndoe; Kumar Sharma; Oliver Smithies; Katalin Susztak; Nobuyuki Takahashi; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

8.  Paeoniflorin prevents diabetic nephropathy in rats.

Authors:  Jianfang Fu; Yuan Li; Li Wang; Bin Gao; Nanyan Zhang; Qiuhe Ji
Journal:  Comp Med       Date:  2009-12       Impact factor: 0.982

9.  Peroxisome proliferator-activated receptors in diabetic nephropathy.

Authors:  Shinji Kume; Takashi Uzu; Keiji Isshiki; Daisuke Koya
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

10.  A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat.

Authors:  Richard E Gilbert; Yuan Zhang; Spencer J Williams; Steven C Zammit; David I Stapleton; Alison J Cox; Henry Krum; Robyn Langham; Darren J Kelly
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.